Showing results (111-120 of 510) with videos related to
Sort By:
Pageof 51
Brain Pathology (Zurich, Switzerland)|February 16, 1999
Oxidative stress in Huntington's diseaseS E Browne, R J Ferrante, M F BealSynapse (New York, N.Y.)|January 1, 1988
Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changesM F Beal, R A Clevens, M F MazurekNeurobiology of Aging|September 1, 1988
Age-related disruption of classical conditioning: a model systems approach to memory disordersP R Solomon, M F Beal, W W PendleburyProgress in Neurobiology|October 9, 1999
Replicating Huntington's disease phenotype in experimental animalsE Brouillet, F Condé, M F Beal, et al.Current Opinion in Neurology|December 1, 1995
Role of nitric oxide in neurodegenerative diseasesJ B Schulz, R T Matthews, M F BealJournal of Neural Transmission. Supplementum|January 1, 1987
Neuropeptides in Alzheimer's diseaseM F Beal, N W Kowall, M F MazurekNeuroscience Letters|August 18, 1987
The regional distribution of somatostatin and neuropeptide Y in control and Alzheimer's disease striatumM F Beal, M F Mazurek, M A McKeeArchives of Neurology|May 1, 1981
Cerebral atheromatous embolism following carotid sinus pressureM F Beal, T S Park, C M FisherNeuroscience Letters|May 27, 1991
2-Chloroadenosine attenuates NMDA, kainate, and quisqualate toxicityS F Finn, K J Swartz, M F BealExperimental Neurology|August 1, 1994
Implanted NGF-producing fibroblasts induce catalase and modify ATP levels but do not affect glutamate receptor binding or NMDA receptor expression in the rat striatumD M Frim, U Wüllner, M F Beal, et al.Pageof 51